Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma ; volume:38 ; number:4 ; day:14 ; month:2 ; year:2024 ; pages:305-314 ; date:4.2024
Annals of nuclear medicine ; 38, Heft 4 (14.2.2024), 305-314, 4.2024
- Creator
-
Niitsu, Hikaru
Fukumitsu, Nobuyoshi
Tanaka, Keiichi
Mizumoto, Masashi
Nakai, Kei
Matsuda, Masahide
Ishikawa, Eiichi
Hatano, Kentaro
Hashimoto, Tsuyoshi
Kamizawa, Satoshi
Sakurai, Hideyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12149-024-01901-z
- URN
-
urn:nbn:de:101:1-2405212103483.539143824103
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Niitsu, Hikaru
- Fukumitsu, Nobuyoshi
- Tanaka, Keiichi
- Mizumoto, Masashi
- Nakai, Kei
- Matsuda, Masahide
- Ishikawa, Eiichi
- Hatano, Kentaro
- Hashimoto, Tsuyoshi
- Kamizawa, Satoshi
- Sakurai, Hideyuki
- SpringerLink (Online service)
Other Objects (12)
Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma
PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]-L-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
11C-Methionine uptake in meningiomas after stereotactic radiotherapy
![Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series
An alternative methodology for the determination of the radiochemical purity of 11C-methionine
[S-methyl-11C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy
Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma
PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]-L-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
11C-Methionine uptake in meningiomas after stereotactic radiotherapy
Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series
An alternative methodology for the determination of the radiochemical purity of 11C-methionine
[S-methyl-11C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy
Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma
PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]-L-Methionine positron emission tomography in the management of children and young adults with brain tumors
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
11C-Methionine uptake in meningiomas after stereotactic radiotherapy
Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series
An alternative methodology for the determination of the radiochemical purity of 11C-methionine